Marex Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$506K Buy
5,840
+1,667
+40% +$160K ﹤0.01% 619
2025
Q4
$401K Sell
4,173
-83,279
-95% -$8.09M ﹤0.01% 626
2025
Q3
$8.33M Buy
87,452
+83,819
+2,307% +$7.71M 0.06% 154
2025
Q2
$317K Sell
3,633
-5,388
-60% -$457K ﹤0.01% 439
2025
Q1
$811K Buy
9,021
+6,032
+202% +$540K 0.02% 261
2024
Q4
$239K Sell
2,989
-62
-2% -$5.37K ﹤0.01% 500
2024
Q3
$275K Sell
3,051
-75,193
-96% -$6.33M 0.01% 397
2024
Q2
$6.16M Buy
78,244
+73,823
+1,670% +$6.05M 0.17% 84
2024
Q1
$385K Buy
4,421
+480
+12% +$41K 0.01% 294
2023
Q4
$325K Buy
3,941
+398
+11% +$30.3K 0.01% 375
2023
Q3
$278K Buy
3,543
+965
+37% +$80.8K 0.04% 162
2023
Q2
$227K Sell
2,578
-568
-18% -$48.9K 0.04% 188
2023
Q1
$254K Buy
+3,146
New +$256K 0.03% 216

Other funds holding MDT

Marex Group's MDT Position: Q1 2026 in Review

Marex Group increased its Medtronic (MDT) stake by 40% in Q1 2026, buying an estimated $160K and bringing the position to 5,840 shares worth $506K. The position accounts for ﹤0.01% of the portfolio, ranked #619.

Marex Group first reported a position in MDT in Q1 2023 and has held it in 13 quarters since. The position peaked at $8.33M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Marex Group held 5,840 shares of Medtronic worth $506K as of Q1 2026.
  • Marex Group bought 1,667 Medtronic shares in Q1 2026, an estimated $160K.
  • Medtronic made up ﹤0.01% of Marex Group's portfolio in Q1 2026, its #619 holding.
  • Marex Group first reported a position in Medtronic in Q1 2023 and has held it in 13 quarters since.
  • Marex Group's Medtronic position peaked at $8.33M in Q3 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.